High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease
Application
US20260083829A1
Kind: A1
Mar 26, 2026
Assignee
Amicus Therapeutics, Inc.
Inventors
Kenneth Valenzano, John Crowley, Richie Khanna, John Flanagan
Abstract
The present application provides for compositions comprising high concentrations of acid α-glucosidase in combination with an active site-specific chaperone for the acid α-glucosidase, and methods for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject such compositions. The present application also provides methods for increasing the in vitro and in vivo stability of an acid α-glucosidase enzyme formulation.
CPC Classifications
A61K 38/47
A61K 9/0019
A61K 31/445
A61K 31/7008
A61K 47/22
C12N 9/2408
C12N 9/96
C12Y 302/0102
Filing Date
2025-09-22
Application No.
19335590